HOME >> MEDICINE >> NEWS
Hope for arthritis stems from within

Leeds bioengineers have developed an innovative technique for cartilage repair combining the self-healing powers of the body with stem cell science to help young people avoid debilitating knee problems and give hope to arthritis sufferers.

Current treatments of cartilage defects in the knee are expensive, have lengthy recovery times, and can even cause as much damage as good. "We're responding to a real need," said reader in bioengineering Dr Bahaa Seedhom.

"Orthopaedic surgeons are looking for ways to repair cartilage defects in young people which will delay, maybe even prevent, the need for total knee replacement."

The bioengineers have invented a repair technique and tools that cut surgery times from two hours to ten minutes, and can have patients back on their feet within three weeks. The treatment involves a surgical technique called subchondral drilling, where holes are drilled into the bone beneath the cartilage in the damaged site, causing bleeding from the bone marrow, which stimulates stem cells to grow tissue within the damaged area. Surgeons then implant a felt-like pad, to encourage the cells to expand and grow into tissue.

As the treatment uses the body's own stem cells, it is much cheaper than existing methods, where tissue is engineered outside the body and then implanted. The system has potential for widescale applications. "Initially young people with small defects will be most suitable for treatment, but once the system has been put through its paces it might well be used for larger defects in older arthritic patients," said Dr Seedhom.


'"/>

Contact: Hannah Love
h.e.b.love@leeds.ac.uk
44-113-343-4100
University of Leeds
30-Jan-2006


Page: 1

Related medicine news :

1. Using coxibs and NSAIDs to treat osteoarthritis
2. Experimental gene therapy abolishes arthritis pain and lessens joint damage
3. Counseling, coping skills could reduce arthritis disability
4. Green tea compound suppresses factors causing cartilage, bone destruction in arthritis
5. Green tea compound may be a therapy for people with rheumatoid arthritis
6. Costs of treating arthritis on the rise nationwide, study finds
7. 1 out of every 3 arthritis sufferers is affected in ability to work
8. The link between rheumatoid arthritis and cancer
9. Assessing the cost of juvenile arthritis
10. Exercise has no effect on risk of knee osteoarthritis
11. The problem with treating spondylarthritis with anti-TNF strategies

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Hope for arthritis stems from within

(Date:5/22/2013)... May 22, 2013 Zensah® Compression Apparel ... News article titled "Breast pain while running ... bras could help." According to the article, a ... a substantial amount suffer from breast pain while running ... correct the issue. , Zensah emphasizes the importance ...
(Date:5/22/2013)... 2013 People in the United States have ... water shortages. In much of the world, water shortages are ... Sharon Kleyne. She warns against taking water for granted and ... available so easily in the United States. , Sharon Kleyne ... radio show, heard live or by podcast on World Talk ...
(Date:5/22/2013)... IA (PRWEB) May 22, 2013 Diversity ... piece Handicap This! The performance promotes awareness that ... dreams. The Handicap This! performance will be held Friday, ... High School auditorium. Tickets for Handicap This! can ... This! helps audiences measure the level to which their ...
(Date:5/22/2013)... ARBORA University of Michigan study challenges previous research ... Baseball. , The study, a collaboration between researchers ... Florida, looks deeper into the controversial argument over ... strikes for pitchers of the same race. It ... said Jason Winfree, associate professor of sport management ...
(Date:5/22/2013)... that hospitals may be reaping enormous income for ... bloodstream infections contracted in their intensive care units. ... in the American Journal of Medical Quality ... who develops an avoidable central line-associated bloodstream infection ... for than a similar infection-free patient. Moreover, hospitals ...
Breaking Medicine News(10 mins):Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 2Health News:Zensah® Comments on New York Daily News Article Examining How Better Sports Bra Could Help Women Marathoners 3Health News:Water Advocate Sharon Kleyne Announces Water Conservation Appreciation 2Health News:Handicap This! Comes to Marion, Iowa 2Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4
(Date:5/22/2013)... Mai 2013 Kepner-Tregoe (KT), das ... heute bekannt, dass der Veteran von 13 ... zum Hauptgeschäftsführer ernannt wurde. Geraghty,s Erfahrung umfasst ... er zahlreiche Führungspositionen bei Fertigungsunternehmen innehielt. Er ... der als Kepner-Tregoe Hauptgeschäftsführer gedient hat, in ...
(Date:5/22/2013)... , May 22, 2013   Upsher-Smith ... completion of its global Phase III clinical ... developed program for the management of epilepsy ... technology.  USL255 is specifically engineered to provide ... topiramate blood levels observed with currently available ...
(Date:5/22/2013)... VIEJO, Calif. , May 22, 2013  Avanir Pharmaceuticals, ... management will present an overview of the company at the ... Care Conference , Presentation date: Wednesday May 29, 2013 ... , Jefferies 2013 Global Healthcare Conference , Presentation date: ... E.T. A live webcast ...
Breaking Medicine Technology:Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 2Kepner-Tregoe, Inc. befördert Chris Geraghty zum Hauptgeschäftsführer 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2
Cached News: